FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

Metagenomi Therapeutics, Inc.: cash_and_restricted_cash

One fact, its scope and the complete path back to the official record.

Period: as of 2023-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/f3045483-4cd9-4b8f-bda7-5827365a8311

Reported value

$101.746M{"amount": 101746000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"}
Entity
Metagenomi Therapeutics, Inc.
Metric
cash_and_restricted_cash
Period
as of 2023-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0000950170-24-059504 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T18:03:58.794982+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001785279/cash-and-restricted-cash/2023-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.